Can a patient on metformin (Metformin) and Ozempic (Semaglutide) 0.25mg use Kenalog (Triamcinolone) for seasonal allergies?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 27, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Patients taking metformin and Ozempic (semaglutide) 0.25mg can generally use Kenalog (triamcinolone) for seasonal allergies, but should consult their healthcare provider first. The combination doesn't typically cause direct interactions, but Kenalog is a corticosteroid that can temporarily raise blood glucose levels, which may affect diabetes management 1. This glucose elevation is usually manageable with regular blood sugar monitoring and possibly temporary adjustments to diabetes medications. According to the 2017 joint task force on practice parameters, intranasal corticosteroids are recommended as the initial treatment for seasonal allergic rhinitis in persons aged 12 years or older 1. However, Kenalog is typically administered via injection, and its use should be considered on a case-by-case basis. Patients should inform their allergist or prescribing physician about all medications they're taking, including metformin and Ozempic. Those with poorly controlled diabetes, severe liver disease, or a history of adverse reactions to steroids should be particularly cautious. The typical Kenalog injection for allergies is administered once per allergy season, with effects lasting several weeks, though individual treatment plans may vary based on symptom severity and medical history.

Key Considerations

  • Regular blood sugar monitoring is crucial when using Kenalog in patients with diabetes
  • Temporary adjustments to diabetes medications may be necessary to manage glucose elevation
  • Patients should inform their healthcare provider about all medications they're taking, including metformin and Ozempic
  • Individual treatment plans may vary based on symptom severity and medical history

Treatment Recommendations

  • Intranasal corticosteroids are recommended as the initial treatment for seasonal allergic rhinitis in persons aged 12 years or older 1
  • Kenalog may be considered for use in patients with seasonal allergies, but its use should be carefully evaluated on a case-by-case basis
  • Patients should consult their healthcare provider before using Kenalog, especially if they have poorly controlled diabetes, severe liver disease, or a history of adverse reactions to steroids.

From the Research

Medication Interactions

  • There is no direct evidence in the provided studies to suggest that Kenalog (Triamcinolone) interacts with Metformin or Ozempic (Semaglutide) in a way that would prevent its use for seasonal allergies 2, 3, 4, 5, 6.
  • Metformin is generally considered safe and well-tolerated, with minimal side effects, and is often used in combination with other medications 2, 3, 6.
  • Ozempic (Semaglutide) is a glucagon-like peptide-1 receptor agonist, and there is no mention of interactions with corticosteroids like Kenalog in the provided studies 3, 6.

Allergic Reactions

  • The study on insulin allergy highlights the importance of diagnosing and managing allergic reactions to medications, but does not provide information on the use of Kenalog with Metformin or Ozempic 4.
  • The treatment of allergic rhinitis with H1-antihistamines and intranasal steroids is discussed in one study, but does not address the use of Kenalog with Metformin or Ozempic 5.

Conclusion Not Applicable

As per the provided instructions, no conclusion or introduction is to be included in the response. The information provided is based on the available evidence and does not include personal opinions or advice.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Role of metformin in the management of type 2 diabetes: recent advances.

Polish archives of internal medicine, 2023

Research

The complexities of insulin allergy: a case and approach.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2021

Research

Treatment of allergic rhinitis: H1-antihistamines and intranasal steroids.

Current drug targets. Inflammation and allergy, 2002

Research

Should metformin remain the first-line therapy for treatment of type 2 diabetes?

Therapeutic advances in endocrinology and metabolism, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.